Tutar, N. Et Al. 2019. Clinical significance of progastrin-releasing peptide, neuron-specific enolase, chromogranin a, and squamous cell cancer antigen in pulmonary neuroendocrine tumors. Turkish Journal of Medical Sciences , vol.49, no.3 , 774-781.

Tutar, N., Yetkin, N. A., Yazıcı, C., Önal, Ö., Kontaş, O., & Keleştemur, F., (2019). Clinical significance of progastrin-releasing peptide, neuron-specific enolase, chromogranin a, and squamous cell cancer antigen in pulmonary neuroendocrine tumors. Turkish Journal of Medical Sciences , vol.49, no.3, 774-781.

Tutar, NURİ Et Al. "Clinical significance of progastrin-releasing peptide, neuron-specific enolase, chromogranin a, and squamous cell cancer antigen in pulmonary neuroendocrine tumors," Turkish Journal of Medical Sciences , vol.49, no.3, 774-781, 2019

Tutar, NURİ Et Al. "Clinical significance of progastrin-releasing peptide, neuron-specific enolase, chromogranin a, and squamous cell cancer antigen in pulmonary neuroendocrine tumors." Turkish Journal of Medical Sciences , vol.49, no.3, pp.774-781, 2019

Tutar, N. Et Al. (2019) . "Clinical significance of progastrin-releasing peptide, neuron-specific enolase, chromogranin a, and squamous cell cancer antigen in pulmonary neuroendocrine tumors." Turkish Journal of Medical Sciences , vol.49, no.3, pp.774-781.

@article{article, author={NURİ TUTAR Et Al. }, title={Clinical significance of progastrin-releasing peptide, neuron-specific enolase, chromogranin a, and squamous cell cancer antigen in pulmonary neuroendocrine tumors}, journal={Turkish Journal of Medical Sciences}, year=2019, pages={774-781} }